Exome Asset Management as of Dec. 31, 2023
Portfolio Holdings for Exome Asset Management
Exome Asset Management holds 52 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Dr Reddys Labs Adr (RDY) | 6.2 | $6.3M | 90k | 69.58 | |
| Eli Lilly & Co. (LLY) | 5.6 | $5.7M | 9.7k | 582.92 | |
| ImmunoGen | 5.5 | $5.5M | 187k | 29.65 | |
| Cigna Corp (CI) | 4.5 | $4.6M | 15k | 299.45 | |
| Celldex Therapeutics Com New (CLDX) | 4.4 | $4.4M | 111k | 39.66 | |
| Tg Therapeutics (TGTX) | 3.4 | $3.5M | 203k | 17.08 | |
| Rhythm Pharmaceuticals (RYTM) | 3.3 | $3.3M | 72k | 45.97 | |
| Alpine Immune Sciences (ALPN) | 3.3 | $3.3M | 174k | 19.06 | |
| Dex (DXCM) | 3.0 | $3.1M | 25k | 124.09 | |
| Madrigal Pharmaceuticals (MDGL) | 3.0 | $3.1M | 13k | 231.38 | |
| Cytokinetics Com New (CYTK) | 2.9 | $2.9M | 35k | 83.49 | |
| Inhibrx (INBX) | 2.7 | $2.8M | 73k | 38.00 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 2.7 | $2.8M | 68k | 40.76 | |
| Rocket Pharmaceuticals (RCKT) | 2.7 | $2.8M | 92k | 29.97 | |
| Bridgebio Pharma (BBIO) | 2.6 | $2.6M | 65k | 40.37 | |
| Beigene Sponsored Adr (BGNE) | 2.3 | $2.3M | 13k | 180.36 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 2.3 | $2.3M | 38k | 60.17 | |
| Penumbra (PEN) | 2.1 | $2.2M | 8.6k | 251.54 | |
| Intuitive Surgical Com New (ISRG) | 2.1 | $2.1M | 6.4k | 337.36 | |
| Biogen Idec (BIIB) | 2.1 | $2.1M | 8.2k | 258.77 | |
| Intra Cellular Therapies (ITCI) | 2.0 | $2.0M | 28k | 71.62 | |
| Biohaven (BHVN) | 1.9 | $1.9M | 46k | 42.80 | |
| Insmed Com Par $.01 (INSM) | 1.9 | $1.9M | 62k | 30.99 | |
| Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 1.8 | $1.8M | 29k | 62.00 | |
| Catalyst Pharmaceutical Partners (CPRX) | 1.8 | $1.8M | 106k | 16.81 | |
| Tarsus Pharmaceuticals (TARS) | 1.7 | $1.7M | 84k | 20.25 | |
| Shattuck Labs (STTK) | 1.6 | $1.6M | 223k | 7.13 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.6 | $1.6M | 3.9k | 406.89 | |
| Immatics SHS (IMTX) | 1.4 | $1.4M | 130k | 10.53 | |
| Prothena Corp SHS (PRTA) | 1.3 | $1.3M | 36k | 36.34 | |
| Geron Corporation (GERN) | 1.3 | $1.3M | 608k | 2.11 | |
| Taysha Gene Therapies Com Shs (TSHA) | 1.2 | $1.2M | 693k | 1.77 | |
| Macrogenics (MGNX) | 1.2 | $1.2M | 126k | 9.62 | |
| Natera (NTRA) | 1.2 | $1.2M | 19k | 62.64 | |
| Igm Biosciences (IGMS) | 1.1 | $1.1M | 136k | 8.31 | |
| Cabaletta Bio (CABA) | 1.0 | $1.1M | 47k | 22.70 | |
| Mirati Therapeutics | 0.9 | $934k | 16k | 58.75 | |
| Pliant Therapeutics (PLRX) | 0.9 | $898k | 50k | 18.11 | |
| Sage Therapeutics (SAGE) | 0.8 | $764k | 35k | 21.67 | |
| Shockwave Med (SWAV) | 0.8 | $762k | 4.0k | 190.56 | |
| Travere Therapeutics (TVTX) | 0.7 | $755k | 84k | 8.99 | |
| Pacific Biosciences of California (PACB) | 0.7 | $739k | 75k | 9.81 | |
| Establishment Labs Holdings Ord (ESTA) | 0.7 | $715k | 28k | 25.89 | |
| Sutro Biopharma (STRO) | 0.7 | $659k | 154k | 4.29 | |
| Eyepoint Pharmaceuticals Com New (EYPT) | 0.6 | $610k | 26k | 23.11 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.6 | $588k | 9.7k | 60.39 | |
| Procaps Group Sa SHS (PROC) | 0.5 | $517k | 127k | 4.07 | |
| Apellis Pharmaceuticals (APLS) | 0.4 | $434k | 7.2k | 59.86 | |
| Gracell Biotechnologies Sponsored Ads | 0.4 | $411k | 41k | 10.04 | |
| Vyne Therapeutics (VYNE) | 0.3 | $275k | 118k | 2.33 | |
| Regulus Therapeutics (RGLS) | 0.2 | $228k | 178k | 1.28 | |
| Kinnate Biopharma (KNTE) | 0.2 | $199k | 84k | 2.37 |
